Roivant Sciences Ltd.
Epperly Melissa B, (Director) reports ROIV insider transactions
AI-generated summary
Director Epperly Melissa B, received 513 shares as a grant on October 23, 2026. On the same date, 116 shares were disposed of through a tax withholding at an average price of $36.49 for a total value of $4,232.84. Following these transactions, the insider directly held 15,351 common shares.
Key facts
- Insider
- Epperly Melissa B, · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | A · grantFootnotes F1 | +513 | $0.00 | $0.00 | 15,467 | Direct |
| Oct 23, 2026 | F · tax withholdingFootnotes F2 | −116 | $36.49 | $4,232.84 | 15,351 | Direct |
Footnotes
- F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
- F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
More ROIV filings
- 4
Filed Oct 30, 2026
- 144
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
- 4
Filed Oct 27, 2026
- SC 13G/A
Filed Oct 27, 2026
- 4
Filed Oct 22, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.